Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-11
DOI
10.3389/fphar.2020.615398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome
- (2020) Elizabeth A Middleton et al. BLOOD
- Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
- (2020) Andrew Clark et al. Lancet Global Health
- Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study
- (2020) Alessandra Vultaggio et al. Journal of Allergy and Clinical Immunology-In Practice
- Ethnic differences in alpha‐1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID‐19 fatality rates
- (2020) Guy Shapira et al. FASEB JOURNAL
- TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection
- (2019) Naoko Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- α 1 -Anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion
- (2018) Huiqing Lin et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
- (2017) Noel G McElvaney et al. Lancet Respiratory Medicine
- Human α1-antitrypsin improves early post-transplant lung function: Pre-clinical studies in a pig lung transplant model
- (2016) Ilker Iskender et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough
- (2015) Bruno Balbi et al. EUROPEAN RESPIRATORY JOURNAL
- Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
- (2015) Kenneth R Chapman et al. LANCET
- α1-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death
- (2013) Wenxi Gao et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Identification and characterization of α1-antitrypsin in fibrin clots
- (2013) S. Talens et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- -1 Antitrypsin Promotes Semimature, IL-10-Producing and Readily Migrating Tolerogenic Dendritic Cells
- (2012) E. Ozeri et al. JOURNAL OF IMMUNOLOGY
- Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
- (2011) I. Tawara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More